Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03120481

Controls for Respiratory Diseases

This is the registry of control participants for patients with various respiratory diseases. We screened healthy volunteers who visited Seoul National Hospital Healthcare System Gangnam Center for routine health check-up, and enrolled patients who agree to participate in the study. The participants undergo baseline questionnaires, provide blood specimen and information of the results of health check-up. We will include participants as controls if they have no significant respiratory symptom and no significant radiographic abnormality. The data from this registry will be compared with those from other registry of various respiratory diseases

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Chronic Obstructive Pulmonary Disease Actinomycetales Infections Asthma Bacterial Infections Bacterial Infections and Mycoses Bronchial Diseases Bronchiectasis Chronic Disease Disease Attributes Gram-Positive Bacterial Infections Hypersensitivity Hypersensitivity, Immediate Idiopathic Pulmonary Fibrosis Immune System Diseases Infections Lung Cancer Lung Diseases Lung Diseases, Interstitial Lung Diseases, Obstructive Lung Neoplasms Mycobacterium Infections Mycobacterium Infections, Nontuberculous Neoplasms Neoplasms by Site Nontuberculous Mycobacterium Infection Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Pulmonary Fibrosis Respiratory Hypersensitivity Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

19 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Healthcare System Gangnam Center

Seoul, 06236, South Korea

Location status: Recruiting

Location contact

Chang-Hoon Lee, M.D.

CONTACT

[email protected]

82-2-2072-4743

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 19-90 years old male and female
  • underwent health check-up including chest radiography
  • obtained informed consent

Exclusion criteria

  • those who showed a significant abnormal finding of chest radiography
  • those who reported a significant respiratory symptoms

Treatment and study plan

No intervation

Other

no intervention

Primary outcomes

  1. Mortality

    Time frame: 20 years

    Death

Secondary outcomes

  1. Hospitalization

    Time frame: 20 years

    All cause hospitalization

  2. Respiratory hospitalization

    Time frame: 20 years

    Hospitalization from respiratory causes

  3. Respiratory diseases diagnosis

    Time frame: 20 years

    Respiratory diseases diagnosis

Study contacts

Contact information is provided by the study sponsor or research team.

Chang-Hoon Lee, M.D.

CONTACT

[email protected]

82-2-2072-4743

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

The Registry of Controls for Respiratory Diseases

Important dates

Study start
2017
Primary completion
2037
Study completion
2037
First posted
Apr 19, 2017
Registry last updated
Apr 19, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.